DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Wiseman GA, Gordon LI, Multani PS. et al.
Ibritumomab tiuxetan radioimmunotherapy for patients with relapsed or refractory non-Hodgkin lymphoma and mild thrombocytopenia: a phase II multicenter trial.
Blood 2002; 99: 4336-4336
We do not assume any responsibility for the contents of the web pages of other providers.